
Hungary postpones vote on law to curb foreign-funded organisations
Viktor Orbán's rightwing populist party, Fidesz, put forward legislation last month that would allow the government to monitor, penalise and potentially ban organisations that receive any sort of foreign funding, including donations or EU grants.
Any organisation could be targeted if it was deemed to 'threaten the sovereignty of Hungary by using foreign funding to influence public life'.
The parliamentary vote had been expected to take place in mid-June. Despite critics likening the legislation to Russia's 'foreign agent' law, it was forecast to be passed by parliament as Fidesz holds a two-thirds majority.
But on Wednesday, Fidesz' parliamentary party leader, Mâté Kocsis, told local media that the vote would be postponed until autumn as the government had received several suggestions regarding the law. 'We are united in our intentions, but there is still debate about the means,' he added on social media.
Civil rights organisations celebrated the delay, with Amnesty International calling it a 'huge joint success'.
'Of course, we can only rest easy once this unlawful bill has been scrapped for good,' the group said on social media. 'Unfortunately, one thing is certain: the government will not give up its attempts to silence independent voices, as has been its goal since 2010.'
Previously, Zoltán Kovács, a spokesperson for the Hungarian government, had said the bill had been introduced amid worries that foreign-funded organisations, primarily from the US and Brussels, were shaping the country's political discourse.
The legislation takes a broad view of what constitutes a threat, describing it as acts undermining Hungary's constitutional identity or Christian culture or challenging the primacy of marriage, the family and biological sexes.
The proposal was swiftly slammed by opposition politicians, who said it would allow the government to potentially shut down all independent media and NGOs engaged in public affairs, while Transparency International described it as a 'dark turning point' for Hungary. 'It is designed to crush dissent, silence civil society, and dismantle the pillars of democracy,' the organisation noted.
The warning was echoed by the Hungarian Helsinki Committee. 'If this bill passes, it will not simply marginalise Hungary's independent voices – it will extinguish them,' co-chair Márta Pardavi said in a statement that described the draft law as 'Operation Starve and Strangle'.
Scores of Hungarians took to the streets in protest while more than 90 editors-in-chief and publishers from across Europe, including from the Guardian, Libération in France and Gazeta Wyborcza in Poland, called on the EU to take action.
Sign up to Headlines Europe
A digest of the morning's main headlines from the Europe edition emailed direct to you every week day
after newsletter promotion
The bill pushed by Orbán – who is facing an unprecedented challenge from a former member of the Fidesz elite, Péter Magyar, ahead of elections next spring – has been described as one of his government's boldest to date. 'Its aim is to silence all critical voices and eliminate what remains of Hungarian democracy once and for all,' a joint statement, signed by more than 300 civil society and media organisations, recently noted.
Magyar was quick to respond to the delayed vote, saying on social media that it would allow the government to 'squeeze even more' out of the proposed bill and 'further divert attention from … the livelihood and housing crisis, Orbán's galloping inflation and the destruction of education'.
The introduction of the draft law in Hungary's parliament had marked an 'escalation' in the government's years of democratic backsliding, said Veronika Móra, the director of the Ökotárs-Hungarian Environmental Partnership Foundation. Many in the country's steadily shrinking civic space had been left rattled by the proposed law and reeling from the uncertainty of what comes next.
'And we've already felt the chilling effects, especially smaller, weaker organisations who were really frightened by the draft law and the potential consequences,' she said. 'So even if it's not passed – which would be great – it's already had an impact.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
14 minutes ago
- Reuters
Exclusive: Buyout groups explore sale of British wealth manager Evelyn, sources say
LONDON, July 28 (Reuters) - Private equity firms Permira and Warburg Pincus are exploring the possible sale of Evelyn Partners, one of the UK's largest wealth managers, three sources with knowledge of the matter said. The owners are working with advisers to prepare for a potential sale of the London-based business towards the end of the year, two of the people said. It could be valued at more than 2.5 billion pounds ($3.36 billion) in a sale, one of the people said. A sale could draw interest from UK banks and private equity investors as well as Canadian and U.S. financial institutions, one of the sources and an industry specialist said. The sources, who requested anonymity because the matter is private, cautioned that the discussions are at an early stage and that no deal is guaranteed. Permira, Warburg Pincus and Evelyn declined to comment. A sale of Evelyn would be the latest in a wave of deals across Europe's wealth management industry as companies hunt for scale and investors look to tap into rising demand for personalised financial advice. Across Europe, 113 asset and wealth management deals were struck in the first six months of 2025, up from 90 in the same period last year, according to data from EY. Deal value also rose to $2.7 billion this year, from $1.9 billion in the same period last year, the data shows. Permira shifted its stake in Evelyn into a continuation fund in 2023, Reuters previously reported. The shareholders had reportedly the year prior considered a sale or initial public offering of the London-based company, but a transaction never materialised. Since then Evelyn has been selling assets. In November 2024 it announced the sale of its accounting business to Apax Partners to refocus on wealth management. It also said it sold its fund solutions business to Thesis in January. Evelyn generated adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of 174.3 million pounds in 2024, an increase of 11.8% from a year earlier, driven by net inflows and investment performance, according to its latest results in March. Permira has owned Evelyn Partners, formerly known as Tilney Smith & Williamson, since 2014, funding its growth from a 5-billion-pound wealth manager to one overseeing 63 billion pounds in client assets. Warburg Pincus became a minority investor in 2020 to fund a merger between Tilney and accounting firm Smith & Williamson. The remainder of the shares are held by current and former staff. Wealth management assets in North America are valued more highly than in the UK, where the pound is also cheaper than the dollar, handing potential U.S. bidders firepower to pay more, one of the three people said. In Europe, wealth managers trade at 15 to 17 times EBITDA compared to around 20 times EBITDA in North America, this person added. U.S. companies have previously targeted the sector including Royal Bank of Canada ( opens new tab, which bought, opens new tab Brewin Dolphin for 1.6 billion pounds in 2022. U.S. financial group Raymond James also struck a 279 million pound deal to take over wealth manager Charles Stanley in 2021. ($1 = 0.7444 pounds)


Reuters
14 minutes ago
- Reuters
EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say
July 28 (Reuters) - The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday. The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact of the tariffs, one of the analysts said. Pharmaceuticals had historically been exempt from duties. Medicines are the largest European exports to the United States by value and the EU accounts for about 60% of all pharmaceutical imports to the U.S. On Sunday, European officials said that a bilateral trade deal for an across-the-board 15% tariff included pharmaceuticals, except for some generic drugs, which would be subject to no tariffs. The U.S. has been conducting a national security investigation into the pharmaceutical sector and the industry has been bracing for separate sectoral tariffs. President Donald Trump said earlier this month, before negotiating the bilateral deal, that pharmaceutical tariffs could be as high as 200%. Some Wall Street analysts said that they do not expect additional tariffs on the EU as a result of the investigation, but others cautioned that the deal was not yet signed and that several questions remained unanswered. UBS analyst Matthew Weston said that he expects details of the trade deal to include protective measures for EU pharma exports from the U.S. investigation, especially since such measures are being discussed in negotiations with the United Kingdom and Switzerland. ING analyst Diederik Stadig also said that while tariffs on top of the 15% were not expected, even after the conclusion of the national security investigations, nothing is completely clear "until a trade deal is inked." Stadig estimates that these levies could add $13 billion to industry expenses without any mitigation strategies, and some of that could be ultimately borne by the consumer. Bernstein analyst Courtney Breen puts the additional expenses at $19 billion for the industry, but she notes that companies might be able to absorb some of the costs with the measures they have been implementing — such as stockpiling of drug products and new deals with contract researchers. Earlier this month, Sanofi ( opens new tab said it will sell a manufacturing facility in New Jersey to Thermo Fisher (TMO.N), opens new tab, where the French drugmaker's therapies will continue to be manufactured. Roche's (ROG.S), opens new tab CEO Thomas Schinecker said last week that the company was increasing its U.S. inventories to avoid any immediate disruption from tariffs. UBS' Weston said that it was not immediately clear which generic drugs were exempted from duties under the deal, but any impact for generic drugmaker Sandoz (SDZ.S), opens new tab for this year should mostly be manageable. Shares in pharmaceutical companies Sanofi, Roche and Sandoz Group all closed up between 0.5% and 1% on Monday.


Daily Mail
14 minutes ago
- Daily Mail
Victorious Lionesses are our 'national pride' say MPs and call for squad to be given damehoods following stunning Euros victory
The Lionesses should be awarded damehoods for the Euro 2025 victory, MPs have declared - hailing the players 'a total inspiration' and 'our national pride'. Tory MP Wendy Morton said the entire England women's football team should be honoured, insisting their collective achievement must not go unrecognised - unlike last time they won. 'These girls have done something extraordinary,' she said. 'They are such an inspiration so they absolutely should receive recognition for that. 'It was a team effort, so they should be honoured as a team. Often the people behind the scenes, and those who practice but don't actually get called to play, miss out on the glory - and they shouldn't.' Fellow Conservative MP Caroline Dinenage also backed calls for official recognition, saying: 'They are our national pride. They showed remarkable resilience, teamwork and strength of character. 'They are a total inspiration and one of our most successful national teams.' The Lionesses captured the nation's hearts with their run of historic victories, and campaigners say it is time their achievements were properly rewarded. When they scored their first historic European Championship victory in 2022, just four of the players got gongs. At the time, honours committee chairman Sir Hugh Robertson said the panel wanted to reward outstanding performances rather than the whole team, as they hadn't won the World Cup. Yesterday, Labour's Sarah Champion MP said she supported giving damehoods to all players '100 per cent'. 'Their courage and dedication to the game has inspired women and girls across the country to get involved with football,' she said. 'It would publicly show that we recognise and celebrate the achievements of women and girls, and they could do the same.' Nigel Huddleston, shadow culture, media and sport minister, said 'honours should be lavished upon the lionesses'. 'The purpose of the honours system is to recognise outstanding contributions and achievements, including in the field of sport,' he said. 'The lionesses have certainly been outstanding. 'While not every member of the team may receive an honour this year, I am confident that most will be recognised over the course of their careers - and deservedly so.' Shadow sports minister Louie French MP added: 'These incredible players deserve to be celebrated and honoured in any way our nation can.' Tory MP Shivani Raja said recognising the Lionesses would show young girls and future athletes what is possible. 'They have once again shown just how powerful and inspiring women's sport can be,' she said. 'Their incredible performances reflect real strength, determination, and talent. We must keep backing brilliant role models like these.' Last night, a Downing Street spokesman hinted that members of the victorious team may be recognised in the honours system, saying: 'There is an independent process for nominations, but I hope we will see lots of nominations for this team.'